19-55401603-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014501.3(UBE2S):c.502G>A(p.Gly168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,606,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014501.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2S | ENST00000264552.14 | c.502G>A | p.Gly168Ser | missense_variant | Exon 4 of 4 | 1 | NM_014501.3 | ENSP00000264552.8 | ||
UBE2S | ENST00000587845.5 | c.589G>A | p.Gly197Ser | missense_variant | Exon 5 of 5 | 2 | ENSP00000467409.1 | |||
RPL28 | ENST00000560055.5 | c.325-1340C>T | intron_variant | Intron 4 of 4 | 3 | ENSP00000452763.1 | ||||
UBE2S | ENST00000589978.1 | c.*185G>A | downstream_gene_variant | 5 | ENSP00000466388.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000210 AC: 48AN: 229098Hom.: 0 AF XY: 0.000229 AC XY: 29AN XY: 126828
GnomAD4 exome AF: 0.000151 AC: 219AN: 1454182Hom.: 0 Cov.: 30 AF XY: 0.000153 AC XY: 111AN XY: 723154
GnomAD4 genome AF: 0.000151 AC: 23AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.502G>A (p.G168S) alteration is located in exon 4 (coding exon 4) of the UBE2S gene. This alteration results from a G to A substitution at nucleotide position 502, causing the glycine (G) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at